You are here: Industry Insights > therapy

News List

DelMar Achieves Two-Thirds Enrollment for Phase 2 Clinical Trial of VAL-083 americanpharmaceuticalreview
August 01, 2019
DelMar Pharmaceuticals has achieved two-thirds enrollment in its ongoing Phase 2 clinical study investigating the first-line treatment of VAL-083 with radiation therapy in newly-diagnosed MGMT-unmethylated GBM.
Lonza, Vineti Enter Cell and Gene Therapy Network Alliance contractpharma
July 31, 2019
Integrated offering includes logistics, scheduling, distribution, Chain of Condition, Chain of Custody, Chain of Identity, and Lonza’s MODA-ES.
KEYTRUDA, Chemotherapy Combination Met Primary Endpoint americanpharmaceuticalreview
July 30, 2019
Merck announced the Phase 3 KEYNOTE-522 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met one of the dual-primary endpoints of pathological complete response (pCR) following the neoadjuvant part of ...
Health Tip: Understanding Exposure Therapy drugs
July 29, 2019
Exposure therapy is a psychological treatment developed to help people confront their fears, says the American Psychological Association (APA).
Testosterone Replacement Therapy May Increase Cardiovascular Risk drugs
July 29, 2019
For aging men with low testosterone levels, testosterone replacement therapy (TRT) may increase the risk of cardiovascular events...
AveXis, BIA Ink Gene Therapy Manufacturing Process Development Deal contractpharma
July 29, 2019
BIA to provide expertise in next generation biomolecule purification processes and long-term supply of CIMmultus monolithic columns.
FDA Approves First Noninjection Glucagon Therapy drugs
July 26, 2019
The U.S. Food and Drug Administration has approved the first noninjection glucagon therapy for emergency treatment of severe hypoglycemia, the agency announced late yesterday.
Myovant reports uterine fibroid combination therapy results July 25, 2019
UK healthcare company Myovant Sciences has announced positive results from LIBERTY 2, its second Phase III study of relugolix combination therapy.
FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia drugs
July 25, 2019
The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of...
Testosterone Therapy May Threaten the Heart drugs
July 24, 2019
Taking testosterone might sound like a good idea for an older man, but a new study suggests the treatment might be bad news for his heart.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page